Company Filing History:
Years Active: 2016
Title: The Innovations of Takahiro Okazawa
Introduction
Takahiro Okazawa is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of immunology, particularly in the detection of specific human T-cells. His work has implications for understanding various immune responses and potential therapeutic applications.
Latest Patents
Takahiro Okazawa holds a patent for a "Marker and reagent for detection of human IL-17-producing helper T cells, and method for detection of human IL-17-producing helper T cells." This invention relates to a marker that allows for the specific detection of human IL-17-producing helper T-cells, also known as human Th17 cells. The method and reagent developed by Okazawa enable researchers to identify these cells accurately, which is crucial for studying immune responses.
Career Highlights
Okazawa is currently employed at Sysmex Corporation, a company known for its innovations in medical diagnostics and laboratory testing. His role at Sysmex has allowed him to further his research and development efforts in the field of immunology.
Collaborations
Takahiro Okazawa has collaborated with notable colleagues such as Satoshi Tanaka and Hitoshi Uga. These collaborations have likely contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Takahiro Okazawa's work in the detection of human IL-17-producing helper T cells represents a significant advancement in immunological research. His contributions through patents and collaborations continue to impact the field positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.